DOI:
10.1055/s-00035026
Applied Clinical Informatics
LinksClose Window
References
Hornik CP, Herring AH, Benjamin Jr DK. , et al; Best Pharmaceuticals for Children Act-Pediatric Trials Network.
Adverse events associated with meropenem versus imipenem/cilastatin therapy in a large retrospective cohort of hospitalized infants.
Pediatr Infect Dis J 2013;
32 (07) 748-753
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.